2.46
-0.115(-4.47%)
Currency In USD
| Previous Close | 2.57 |
| Open | 2.62 |
| Day High | 2.67 |
| Day Low | 2.44 |
| 52-Week High | 3.94 |
| 52-Week Low | 0.69 |
| Volume | 6.55M |
| Average Volume | 6.69M |
| Market Cap | 494.8M |
| PE | -4.55 |
| EPS | -0.54 |
| Moving Average 50 Days | 2.36 |
| Moving Average 200 Days | 1.66 |
| Change | -0.12 |
If you invested $1000 in Esperion Therapeutics, Inc. (ESPR) 10 years ago, it would be worth $100.99 as of October 10, 2025 at a share price of $2.455. Whereas If you bought $1000 worth of Esperion Therapeutics, Inc. (ESPR) shares 5 years ago, it would be worth $75.28 as of October 10, 2025 at a share price of $2.455.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Esperion Announces Pricing of Public Offering of Common Stock
GlobeNewswire Inc.
Oct 08, 2025 1:29 AM GMT
ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medici
Esperion Announces Proposed Public Offering of Common Stock
GlobeNewswire Inc.
Oct 07, 2025 8:01 PM GMT
ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medici
Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 19, 2040
GlobeNewswire Inc.
Oct 03, 2025 12:00 PM GMT
ANN ARBOR, Mich., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Dr. Reddy’s Laboratories, Inc. and its affiliate Dr. Reddy’s Laboratories Ltd. (together, Dr. Reddy’s L